BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

472 related articles for article (PubMed ID: 11034421)

  • 1. CD4+ T lymphocytes with constitutive CD40 ligand in preautoimmune (NZB x NZW)F1 lupus-prone mice: phenotype and possible role in autoreactivity.
    Lettesjö H; Burd GP; Mageed RA
    J Immunol; 2000 Oct; 165(7):4095-104. PubMed ID: 11034421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Separation of the New Zealand Black genetic contribution to lupus from New Zealand Black determined expansions of marginal zone B and B1a cells.
    Atencio S; Amano H; Izui S; Kotzin BL
    J Immunol; 2004 Apr; 172(7):4159-66. PubMed ID: 15034028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism of action of combined short-term CTLA4Ig and anti-CD40 ligand in murine systemic lupus erythematosus.
    Wang X; Huang W; Mihara M; Sinha J; Davidson A
    J Immunol; 2002 Feb; 168(4):2046-53. PubMed ID: 11823542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abrogation of pathogenic IgG autoantibody production in CD40L gene-deleted lupus-prone New Zealand Black mice.
    Pau E; Chang NH; Loh C; Lajoie G; Wither JE
    Clin Immunol; 2011 May; 139(2):215-27. PubMed ID: 21414847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. pConsensus peptide induces tolerogenic CD8+ T cells in lupus-prone (NZB x NZW)F1 mice by differentially regulating Foxp3 and PD1 molecules.
    Singh RP; La Cava A; Hahn BH
    J Immunol; 2008 Feb; 180(4):2069-80. PubMed ID: 18250412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD4+ T cells from (New Zealand Black x New Zealand White)F1 lupus mice and normal mice immunized against apoptotic nucleosomes recognize similar Th cell epitopes in the C terminus of histone H3.
    Fournel S; Neichel S; Dali H; Farci S; Maillère B; Briand JP; Muller S
    J Immunol; 2003 Jul; 171(2):636-44. PubMed ID: 12847228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IFN-alpha induces early lethal lupus in preautoimmune (New Zealand Black x New Zealand White) F1 but not in BALB/c mice.
    Mathian A; Weinberg A; Gallegos M; Banchereau J; Koutouzov S
    J Immunol; 2005 Mar; 174(5):2499-506. PubMed ID: 15728455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-CD40 ligand antibody treatment prevents the development of lupus-like nephritis in a subset of New Zealand black x New Zealand white mice. Response correlates with the absence of an anti-antibody response.
    Early GS; Zhao W; Burns CM
    J Immunol; 1996 Oct; 157(7):3159-64. PubMed ID: 8816428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An Ig mu-heavy chain transgene inhibits systemic lupus erythematosus immunopathology in autoimmune (NZB x NZW)F1 mice.
    Wellmann U; Letz M; Schneider A; Amann K; Winkler TH
    Int Immunol; 2001 Dec; 13(12):1461-9. PubMed ID: 11717187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic dissection of systemic lupus erythematosus pathogenesis: evidence for functional expression of Sle3/5 by non-T cells.
    Sobel ES; Morel L; Baert R; Mohan C; Schiffenbauer J; Wakeland EK
    J Immunol; 2002 Oct; 169(7):4025-32. PubMed ID: 12244205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expansion and hyperactivity of CD1d-restricted NKT cells during the progression of systemic lupus erythematosus in (New Zealand Black x New Zealand White)F1 mice.
    Forestier C; Molano A; Im JS; Dutronc Y; Diamond B; Davidson A; Illarionov PA; Besra GS; Porcelli SA
    J Immunol; 2005 Jul; 175(2):763-70. PubMed ID: 16002672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A subset of CD4+ T cells expressing early activation antigen CD69 in murine lupus: possible abnormal regulatory role for cytokine imbalance.
    Ishikawa S; Akakura S; Abe M; Terashima K; Chijiiwa K; Nishimura H; Hirose S; Shirai T
    J Immunol; 1998 Aug; 161(3):1267-73. PubMed ID: 9686587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cutting edge: lupus susceptibility interval Sle3/5 confers responsiveness to prolactin in C57BL/6 mice.
    Peeva E; Gonzalez J; Hicks R; Diamond B
    J Immunol; 2006 Aug; 177(3):1401-5. PubMed ID: 16849443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polyclonal B cell activation arises from different mechanisms in lupus-prone (NZB x NZW)F1 and MRL/MpJ-lpr/lpr mice.
    Merino R; Iwamoto M; Fossati L; Izui S
    J Immunol; 1993 Dec; 151(11):6509-16. PubMed ID: 7902378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autoreactive B cells in lupus-prone New Zealand black mice exhibit aberrant survival and proliferation in the presence of self-antigen in vivo.
    Chang NH; MacLeod R; Wither JE
    J Immunol; 2004 Feb; 172(3):1553-60. PubMed ID: 14734734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased frequency of circulating follicular helper T cells in lupus patients is associated with autoantibody production in a CD40L-dependent manner.
    Xu H; Liu J; Cui X; Zuo Y; Zhang Z; Li Y; Tao R; Li Y; Pang J
    Cell Immunol; 2015 May; 295(1):46-51. PubMed ID: 25748125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of anti-CD154 treatment on B cells in murine systemic lupus erythematosus.
    Wang X; Huang W; Schiffer LE; Mihara M; Akkerman A; Hiromatsu K; Davidson A
    Arthritis Rheum; 2003 Feb; 48(2):495-506. PubMed ID: 12571860
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protection against renal disease in (NZB x NZW)F(1) lupus-prone mice after somatic B cell gene vaccination with anti-DNA immunoglobulin consensus peptide.
    Ferrera F; Hahn BH; Rizzi M; Anderson M; Fitzgerald J; Millo E; Indiveri F; Shi FD; Filaci G; La Cava A
    Arthritis Rheum; 2007 Jun; 56(6):1945-53. PubMed ID: 17530718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of the CD40/CD40L role in the sustenance of alloreactive antibody production.
    Shoker AS; Lun ZR; Choudry R; Saxena A
    Transpl Immunol; 2001 Feb; 8(4):219-28. PubMed ID: 11316064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences between CD8+ T cells in lupus-prone (NZB x NZW) F1 mice and healthy (BALB/c x NZW) F1 mice may influence autoimmunity in the lupus model.
    Karpouzas GA; La Cava A; Ebling FM; Singh RR; Hahn BH
    Eur J Immunol; 2004 Sep; 34(9):2489-99. PubMed ID: 15307181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.